Growth Metrics

Volitionrx (VNRX) Amortization - Intangibles (2025)

Volitionrx posted quarterly Amortization - Intangibles of $902212.0 for Q4 2025, up 23.65% on a QoQ basis from $729630.0 in Q3 2025.

Volitionrx (VNRX) has 1 years of Amortization - Intangibles data on file, last reported at $902212.0 in Q4 2025.

  • For the quarter ending Q4 2025, Amortization - Intangibles changed N/A year-over-year to $902212.0; the trailing twelve-month figure through Dec 2025 stood at $2.0 million (changed N/A YoY), and the FY2025 full-year result was $2.0 million, changed N/A from the prior year.
  • Amortization - Intangibles for Q4 2025 stood at $902212.0, up from $729630.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $902212.0 in Q4 2025 and bottomed at $325305.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Volitionrx 101.83 Mn 99.36 Mn -1.01 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 902,212.00
Sep 30, 2025 729,630.00
Jun 30, 2025 325,305.00